TriMas (TRS) Q3 2026: Fourth straight beat with $1.16 billion still to deploy
As seen on the 24/7 Wall St. homepage on October 29, 2026.
Fourth straight quarter above consensus, with continuing-operations sales up 7.7%, and management raised full-year sales growth guidance to 4% to 6%. A $1.16 billion cash pile is still waiting to be deployed.
Continue ReadingShow less
TriMas posted adjusted diluted EPS of $0.50 for Q3 2026, beating expectations for the fourth consecutive quarter. That run of consistency is hard to dismiss as noise.
Year-over-year comparisons look steep only because the Aerospace segment, sold in March 2026, is now classified as discontinued operations. Within continuing operations, net sales rose 7.7%. Packaging, the larger remaining segment, carried the growth.
Specialty Products was the soft spot, growing revenue only 2.7% while absorbing throughput difficulties at Norris Cylinder, where manufacturing inefficiencies and lagging raw material cost recovery weighed on profit. CEO Thomas Snyder acknowledged the drag, saying results have "not yet fully reflected the benefits of these actions" while pointing to progress in operational leadership and productivity initiatives.
Sponsored
Management raised the low end of full-year sales growth guidance to 4% and reaffirmed adjusted diluted EPS guidance of $1.60 to $1.70. The $1.16 billion cash balance from divestiture proceeds is already contributing interest income while it waits to be put to work.
TriMas repurchased $82.7 million of stock year to date, with room left on the current buyback authorization. A deal to sell the Rapak bag-in-box product line is expected to close in November 2026 as management narrows its focus and eyes acquisitions with the Aerospace proceeds.
Sources
Mentioned: TRS